|
HS Code |
359163 |
As an accredited 3,7-Dibromodibenzothiophene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3,7-Dibromodibenzothiophene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
3,7-Dibromodibenzothiophene is not the sort of compound that jumps off the shelf at the local hardware store. It belongs to a family of sulfur-containing polycyclic aromatics that carve out unique territory in chemical synthesis and advanced research. My own work in laboratory preparation and scale-up research has shown that finding consistently pure intermediates makes or breaks a project’s timeline, especially in heterocycles where sulfur and halogens are involved. For those committed to new materials or innovative pharmaceutical exploration, this compound fills some noticeable gaps where both reactivity and selectivity matter.
People new to the scene or just starting to dabble in organic electronics might be wondering what sets 3,7-dibromodibenzothiophene apart. It doesn’t look much different from other dibrominated biaryls at first glance. The real difference sits in its structural symmetry, bromine positions, and the sulfur atom’s role. This arrangement shifts reactivity patterns during coupling reactions. Solid evidence points toward better precision during cross-coupling or Suzuki reactions, an asset in custom molecule design where unwanted side products can burn a lot of time and money.
Chemists often face a wall when looking for robust intermediates for organic semiconductors or pharmaceutical leads. Years ago, I took on a project connecting thieno-based small molecules for flexible OLED prototypes. Every tiny substituent made a world of difference. 3,7-Dibromodibenzothiophene, with its pre-positioned bromines, offered a reliable launchpad for further substitution. Unlike the less symmetrical 4,6-derivatives, the 3,7 compound supported better product control during Pd-catalyzed processes. Fewer byproduct headaches made downstream purification more straightforward.
Each batch I worked with came off the line as an off-white solid, melting between 104°C and 108°C. This consistency eased up on the headaches common to products with broader melting ranges—something that often signals impurities. Purity here isn’t just an academic target; it translates directly to yield optimization and reproducibility, two qualities that keep research budgets in line and projects moving.
Beyond the lab, industrial users want materials that fit into larger production streams. 3,7-Dibromodibenzothiophene stands out because its unique symmetry and bromine placement boost overall efficiency during aryl-aryl couplings. Considering the push for more sustainable chemistry, the sharper selectivity also means less starting material gets lost as waste. Less clean-up, fewer solvent cycles, clear environmental gains.
Chemistry is notorious for offering endless versions of nearly identical molecules. Dibenzothiophene derivatives fill databases with dozens of entries. It’s easy to say, “one is just as good as another,” but that has never mirrored my hands-on experience.
Take 4,6-dibromodibenzothiophene or those with mixed halogenation (bromo-chloro, bromo-iodo). Irregular substitution positions create reactivity quirks during transition metal catalysis. I’ve had entire weeks wasted cleaning up intractable mixtures from poorly chosen building blocks. The 3,7-dibromo arrangement, in contrast, minimizes steric crowding while giving a clean target for metal insertion during organometallic reactions. These advantages might sound subtle while reading them, but at the bench, they mean going home on time.
People working with derivatives for medical chemistry or materials science always appreciate molecules that connect where you expect them to, rather than scrambling into several isomers. This dibromo compound supports building blocks for antitumor agents as well as organic light-emitting diodes. Its versatility comes from those reliable, predictable points of reactivity.
Let’s talk why someone might reach for this compound over alternative brominated organics. In the quest for new pharmaceuticals, dibenzothiophenes play key roles as backbone fragments. Brominated versions, especially the 3,7 arrangement, act as springboards for cross-couplings that link up the next generation of active compounds. Their sulfur content brings unique binding properties in protein targets.
For those working in polymer science, the same compound is picking up momentum in the search for stable, high-mobility organic semiconductors. Researchers in Japan reported better hole transport in devices built around 3,7-dibromodibenzothiophene derivatives compared to more basic aromatic units. This could mean thinner, tougher, more efficient flexible displays or solar panels in the years ahead.
I remember running a batch for a custom polymer scaffold. Standard biphenyls would not hold up to the electron demand needed for my project. When switched to a dibenzothiophene core with bromines in the 3,7 positions, yield jumped close to 90%, plus the finished films showed less warping under heat. This didn’t just save a few hours; it kept the project’s funding rolling.
End-users can never turn a blind eye to technical data, and rightfully so. 3,7-Dibromodibenzothiophene’s CAS number, 132-85-4, pops up in major chemical databases. Mass spectrometry confirms a molecular weight close to 340.07 g/mol. Elemental analysis matches C12H6Br2S, with less than 1% deviation in reputable, research-grade suppliers. Most suppliers ship this compound with purity above 97% by HPLC, making it suitable for demanding syntheses and hard-to-purify downstream targets.
Visual inspection reveals a dense, off-white crystalline solid—no tell-tale signs of unreacted dibenzothiophene, no haloed shades that speak to oxidation. It dissolves well in common organic solvents like dichloromethane, chloroform, and THF. I’ve found its solubility profile lets it blend smoothly into reaction setups, giving less trouble during filtration and solvent switches. That’s not always true for similar compounds, where partial solubility wastes a lot of starting material.
In terms of stability, this compound stores well at room temperature in dry, dark conditions. Some chemists get skittish about brominated organics after run-ins with more flighty aryl bromides, but here, the molecular framework holds up over time. No piles of decomposition products, even months after opening.
Labs everywhere know the pain of sourcing chemicals that match catalog claims. I’ve personally been stung by inconsistent batches from discount sources, especially in halogenated frameworks. A major issue with lower-quality 3,7-dibromodibenzothiophene is off-target substitution—leftover mono-brominated or over-brominated byproducts. Even trace amounts impact complex coupling reactions down the line. Sourcing from trusted suppliers with certificates of analysis and NMR proof is the only way I’ve found to sidestep mid-project surprises.
Once you’ve got a reliable stock, watch general good practices: gloves on, good ventilation, and attention to minimizing exposure. The dust isn’t high risk, but its bromine groups mean it should not be casually handled. Prefer single-use, preweighed containers for consistent dosing, especially as reactions scale up. Over the years, losses mostly came from poor sealing or careless weighing. It pays to have a system, especially for expensive or multi-step reactions.
Disposal should follow standard protocols for halogenated organics. Close that loop, because improper handling not only endangers local water tables—regulators have been ramping up enforcement for industrial discharge. Proper segregation means fewer compliance headaches.
Over the past decade, the landscape for dibenzothiophene derivatives shifted away from academic curiosity toward high-value applications. Patent searches reveal a steady uptick in filings that list this compound somewhere in the methodology. Researchers have pivoted toward more sustainable electronics and specialty pharmaceuticals, increasing pressure on both quality control and batch reproducibility.
Volume demand is unlikely to match bulk chemicals such as toluene or phenol, but the margin per gram tells a different story. Companies supporting OLED development or next-gen agrochemical research need reliable intermediates with minimal regulatory fuss. That has nudged commercial labs to raise the bar on batch purity and documentation. The best examples come with NMR, MS, and HPLC traces straight from QC analysis—no room for shortcuts. Projects live or die by these certificates, because in major research programs, “close enough” isn’t actually close enough.
Regulatory bodies worldwide now require more data for every new chemical entity’s lifecycle. Even intermediates destined for further transformation need traceability. This product’s straightforward synthesis and stable storage profile have helped it stay relevant as supply chains become more transparent and vertically integrated.
Spending long hours in front of fume hoods, pushing a reaction that just refuses to finish, makes a lasting impression on how much starting material quality matters. 3,7-Dibromodibenzothiophene, in my hands, trims frustration out of the routine. Compared to monobromo analogs, the di-bromo pattern lends a better-defined stopping point for next-step substitutions. The sulfur atom’s position provides physical robustness that makes chromatography and crystallization less painful.
Working side by side with grad students and seasoned postdocs, I’ve watched how the product streamlines workflows. Experienced chemists spot the benefit in easier monitoring over TLC and fewer ghost spots during purity checks. For folks focusing on library generation—turning out dozens of derivatives in short timeframes—anything that reduces purification cycles gets a big thumbs up.
It also scales. Projects that start in milligram flasks routinely step up to gram or even multigram scales with this compound. Reaction exotherms stay manageable. Waste streams need less triage because the byproducts remain predictable. This makes multistep sequences more practical for startup teams who don’t have access to million-dollar waste management infrastructure.
Accessibility often defines whether an academic or industrial project progresses or goes on hold. Five or ten years ago, niche heterocycles like this one often ran into two bottlenecks: sky-high costs and spotty availability. Today’s global network of specialty suppliers changed the game. Research teams working everywhere from Boston to Bangalore can find research-scale lots at fair prices. Still, price per gram hovers higher than that for generic aryl bromides, so budget-conscious teams typically plan reactions carefully.
Bulk buyers and industrial scale-up engineers find the process even more cost-sensitive. Shipping brominated organics falls under stricter hazard codes, pumping up fees. Some firms look for ways to synthesize this compound in-house, but in my experience, time spent fiddling with bromination protocols rarely pays off compared to direct sourcing from reliable suppliers.
To offset costs, some research groups pool buying power or coordinate large, multi-institute orders. Others mix-and-match procurement with derivative design to maximize every purchased batch. My suggestion from the field: don’t try to shoehorn cheaper, structurally similar analogs into protocols that count on 3,7-dibromodibenzothiophene. The cost in rework and failed experiments often outweighs the upfront savings.
Green chemistry, sustainability, and life-cycle analysis are rising priorities everywhere chemicals connect. Bromine- and sulfur-containing aromatics get close attention because they bring both environmental opportunities and challenges. From my experience, 3,7-dibromodibenzothiophene’s higher selectivity during targeted substitutions translates to fewer dirty byproducts and less spent solvent in the waste stream. This isn’t just a feel-good story—labs face major scrutiny for every drum of halogenated waste that leaves the building.
Manufacturers make better choices today, bundling shipping with detailed MSDS and hazard profiles, easing compliance burdens for smaller labs and large industrial sites alike. It’s a real win when a product’s reliability supports greener chemistry and tighter regulatory conformance with minimal added effort.
Future-oriented teams also scope options for recycling leftover brominated intermediates and streamlining halogen recovery. Closed-loop practices are catching on, prompted partly by cost but also by duty to future generations. The relatively clean reactivity profile of this compound fits well into such efforts, reducing cross-contamination and easing the burden on regenerative purification setups.
The synthetic world always wants better. If you ask colleagues what they wish for with 3,7-dibromodibenzothiophene, a few themes stand out. First, improved transparency in trace impurity analysis. As downstream targets become more sensitive, even 97% purity sometimes leaves too much wiggle room. Pathways to reach 99% or higher without breaking chemists’ budgets would offer real value.
Certainty in supply is another big wish. Periodic shipping delays, customs slowdowns, or regulatory snags can paralyze a program. Reliable, on-time supply chains based on real-time stock data would change the landscape, letting scientists focus energy on actual research instead of endless procurement ping-pong.
Ease of customization counts, too. Some fields—especially those working on proprietary molecule libraries—benefit when suppliers support custom-lot syntheses or special handling. Whether it’s kilogram-scale delivery for pilot runs or kilogram-scale supply for industrial processes, flexibility would unlock new applications, especially as technology evolves.
To close obvious gaps, collaboration between academic groups, ink manufacturers, and specialty reagent suppliers could push forward standardized impurity analysis for common intermediates like this one. Clearer labels, easy-to-search batch data, and faster direct support lines would work wonders.
Some forward-thinking suppliers joined forces with logistic partners to map smarter supply chains. Teaming up with distributors close to research clusters cuts down lead times while shrinking each shipment’s carbon footprint. Moving to just-in-time inventory models combines the benefits of stability and cost-control while ensuring fresh product hits the bench.
In-house or consortia-run recycling centers for leftover brominated compounds present another smart step. Bigger industrial players already recover and reuse significant fractions of organobromine content from byproducts. Academic labs, by getting creative and banding together, could tap into similar benefits, reducing their environmental load, overhead, and regulatory headaches all at once.
On the technical side, adopting new catalytic protocols not only increases yield but also cuts the generation of hard-to-process impurities. Using ligand-accelerated Pd-catalyzed couplings, for example, trims side reactions. Modern analytical techniques—online HPLC, process NMR, automated in-line purification—keep labs on target and flag trouble before it cascades down the workflow. These practices favor compounds with clear, robust structures like 3,7-dibromodibenzothiophene.
From academic bench tops to pilot-scale production runs in electronics, 3,7-dibromodibenzothiophene has stepped up as more than a chemical curiosity. Its unique bromination pattern, reliable reactivity, and tight specs have solved plenty of real-world problems for those of us who have spent months troubleshooting complex syntheses. Its ongoing story tracks real shifts in how science tackles small-molecule development, sustainability, and workflow automation.
The takeaway: As researchers shift toward more complex organic frameworks for both health and advanced materials, the choice of intermediates becomes less about what’s available and more about what delivers on expectations. With robust quality, reliable supply, and a track record for clean transformations, this compound is likely to stick around in the toolkit of any progressive lab or industry innovator. Here, the core value shows up not just on reaction charts, but through the confidence it gives to those pushing the boundaries of modern science.